Report Detail

Pharma & Healthcare Global (United States, European Union and China) Geriatric Medicine Market Research Report 2019-2025

  • RnM3648375
  • |
  • 06 August, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults
One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base. Furthermore, the rising prevalence of various target diseases, decreasing immunity levels, and the significant improvements in the healthcare systems across the globe is also significantly driving the market growth.
In 2019, the market size of Geriatric Medicine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Geriatric Medicine.

This report studies the global market size of Geriatric Medicine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Geriatric Medicine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.

Market Segment by Product Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant

Market Segment by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Geriatric Medicine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Geriatric Medicine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Geriatric Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Geriatric Medicine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Analgesics
      • 1.3.3 Antihypertensives
      • 1.3.4 Statins
      • 1.3.5 Antidiabetics
      • 1.3.6 Proton Pump Inhibitor
      • 1.3.7 Anticoagulant
      • 1.3.8 Antipsychotic
      • 1.3.9 Antidepressant
    • 1.4 Market Segment by Application
      • 1.4.1 Global Geriatric Medicine Market Share by Application (2019-2025)
      • 1.4.2 Cardiovascular
      • 1.4.3 Arthritis
      • 1.4.4 Neurological
      • 1.4.5 Cancer
      • 1.4.6 Osteoporosis
      • 1.4.7 Respiratory
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Geriatric Medicine Market Size
      • 2.1.1 Global Geriatric Medicine Revenue 2014-2025
      • 2.1.2 Global Geriatric Medicine Sales 2014-2025
    • 2.2 Geriatric Medicine Growth Rate by Regions
      • 2.2.1 Global Geriatric Medicine Sales by Regions 2014-2019
      • 2.2.2 Global Geriatric Medicine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Geriatric Medicine Sales by Manufacturers
      • 3.1.1 Geriatric Medicine Sales by Manufacturers 2014-2019
      • 3.1.2 Geriatric Medicine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Geriatric Medicine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Geriatric Medicine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Geriatric Medicine Price by Manufacturers
    • 3.4 Key Manufacturers Geriatric Medicine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Geriatric Medicine Market
    • 3.6 Key Manufacturers Geriatric Medicine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Analgesics Sales and Revenue (2014-2019)
      • 4.1.2 Antihypertensives Sales and Revenue (2014-2019)
      • 4.1.3 Statins Sales and Revenue (2014-2019)
      • 4.1.4 Antidiabetics Sales and Revenue (2014-2019)
      • 4.1.5 Proton Pump Inhibitor Sales and Revenue (2014-2019)
      • 4.1.6 Anticoagulant Sales and Revenue (2014-2019)
      • 4.1.7 Antipsychotic Sales and Revenue (2014-2019)
      • 4.1.8 Antidepressant Sales and Revenue (2014-2019)
    • 4.2 Global Geriatric Medicine Sales Market Share by Type
    • 4.3 Global Geriatric Medicine Revenue Market Share by Type
    • 4.4 Geriatric Medicine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Geriatric Medicine Sales by Application

    6 United States

    • 6.1 United States Geriatric Medicine Breakdown Data by Company
    • 6.2 United States Geriatric Medicine Breakdown Data by Type
    • 6.3 United States Geriatric Medicine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Geriatric Medicine Breakdown Data by Company
    • 7.2 European Union Geriatric Medicine Breakdown Data by Type
    • 7.3 European Union Geriatric Medicine Breakdown Data by Application

    8 China

    • 8.1 China Geriatric Medicine Breakdown Data by Company
    • 8.2 China Geriatric Medicine Breakdown Data by Type
    • 8.3 China Geriatric Medicine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Geriatric Medicine Breakdown Data by Company
    • 9.2 Rest of World Geriatric Medicine Breakdown Data by Type
    • 9.3 Rest of World Geriatric Medicine Breakdown Data by Application
    • 9.4 Rest of World Geriatric Medicine Breakdown Data by Countries
      • 9.4.1 Rest of World Geriatric Medicine Sales by Countries
      • 9.4.2 Rest of World Geriatric Medicine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GSK
      • 10.1.1 GSK Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.1.4 Geriatric Medicine Product Introduction
      • 10.1.5 GSK Recent Development
    • 10.2 Boehringer Ingelheim
      • 10.2.1 Boehringer Ingelheim Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.2.4 Geriatric Medicine Product Introduction
      • 10.2.5 Boehringer Ingelheim Recent Development
    • 10.3 Novartis
      • 10.3.1 Novartis Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.3.4 Geriatric Medicine Product Introduction
      • 10.3.5 Novartis Recent Development
    • 10.4 Bristol-Myers Squibb
      • 10.4.1 Bristol-Myers Squibb Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.4.4 Geriatric Medicine Product Introduction
      • 10.4.5 Bristol-Myers Squibb Recent Development
    • 10.5 Pfizer
      • 10.5.1 Pfizer Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.5.4 Geriatric Medicine Product Introduction
      • 10.5.5 Pfizer Recent Development
    • 10.6 Eli Lilly
      • 10.6.1 Eli Lilly Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.6.4 Geriatric Medicine Product Introduction
      • 10.6.5 Eli Lilly Recent Development
    • 10.7 Abbott
      • 10.7.1 Abbott Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.7.4 Geriatric Medicine Product Introduction
      • 10.7.5 Abbott Recent Development
    • 10.8 AstraZeneca
      • 10.8.1 AstraZeneca Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.8.4 Geriatric Medicine Product Introduction
      • 10.8.5 AstraZeneca Recent Development
    • 10.9 Merck
      • 10.9.1 Merck Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.9.4 Geriatric Medicine Product Introduction
      • 10.9.5 Merck Recent Development
    • 10.10 Sanofi S.A.
      • 10.10.1 Sanofi S.A. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Geriatric Medicine
      • 10.10.4 Geriatric Medicine Product Introduction
      • 10.10.5 Sanofi S.A. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Geriatric Medicine Sales Channels
      • 11.2.2 Geriatric Medicine Distributors
    • 11.3 Geriatric Medicine Customers

    12 Market Forecast

    • 12.1 Global Geriatric Medicine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Geriatric Medicine Sales Forecast by Type
    • 12.3 Global Geriatric Medicine Sales Forecast by Application
    • 12.4 Geriatric Medicine Forecast by Regions
      • 12.4.1 Global Geriatric Medicine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Geriatric Medicine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Geriatric Medicine. Industry analysis & Market Report on Geriatric Medicine is a syndicated market report, published as Global (United States, European Union and China) Geriatric Medicine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Geriatric Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,433.60
      765,650.40
      1,020,867.20
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report